Cronos Group Inc. Common Share (CRON)

FairStock Score: 49/100 — MIXED

Key Financials

Strengths

• Conservative balance sheet with debt-to-equity of just 0.00, providing financial flexibility
• Altman Z-Score of 12.4 confirms minimal bankruptcy risk and strong solvency
• Revenue growth of 47.0% demonstrates strong top-line momentum

Concerns

• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration

AI Analysis

Cronos Group Inc. Common Share is a micro-cap healthcare company valued at $989 million. Revenue stands at $160 million, though the company is currently unprofitable. From a quality standpoint, Cronos shows Altman Z-Score of 12.4 confirms fortress-level solvency and modest 0% ROE. On valuation, the stock is 1.0% FCF yield. Growth dynamics show revenue growing at 47.0% and profit growth of -104.2%. Our composite FairStock Score of 49/100 reflects mixed fundamentals overall. Without profitability, this remains speculative—suitable only for those with high risk tolerance and a long time horizon.

Bull Case

Cronos's 47% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer